Physician profile
Robert Ruggiero
NPI 1255342705
$693.28
in general payments reported to CMS, 2019-2025
18 companies · $43.27 in 2025
The $43.27 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $395 · 2020: $30.68 · 2021: $49.66 · 2022: $32.06 · 2023: $83.13 · 2024: $59.75 · 2025: $43.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $186.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $110.61 | 2019-2021 | |
| Depuy Synthes Sales INC. | $90.65 | 2019-2020 | |
| Stryker Corporation | $62.94 | 2023 | Optablate, Omnicurve |
| Zimmer Biomet Holdings, INC. | $59.75 | 2024 | Gel-One Cross-Linked Hyaluronate |
| Fidia Pharma USA INC. | $49.37 | 2019 | |
| Xtant Medical INC | $43.27 | 2025 | |
| Janssen Biotech, INC. | $35.60 | 2019 | |
| Amgen INC. | $34.31 | 2019 | |
| Sanofi-Aventis U.S. LLC | $32.70 | 2019 | |
| Radius Health, INC. | $30.64 | 2021 | |
| Bioventus LLC | $29.22 | 2019-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $20.19 | 2023 | Jublia |
| Glaxosmithkline, LLC. | $18.61 | 2022 | |
| Abbvie INC. | $18.58 | 2019 | |
| Integra Lifesciences Corporation | $15.91 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $14.99 | 2019 | |
| Acell, INC. | $13.10 | 2019 | |
| Merck Sharp & Dohme LLC | $12.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Ruggiero listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.